Print this page

Home - Department of Molecular Microbiology & Immunology

  • mmi_banner_6
  • mmi_banner_7
  • mmi_banner_1
  • mmi_banner_2
  • mmi_banner_8
  • mmi_banner_4
  • mmi_banner_5
mmi_banner_61 mmi_banner_72 mmi_banner_13 mmi_banner_24 mmi_banner_85 mmi_banner_46 mmi_banner_57

Saint Louis University Medical Center | Edward A. Doisy Research Center
Rm 716 | 1100 South Grand | St. Louis, Missouri 63104
Phone 314.977.8850 Fax 314.977-8717 | Email:

Key Features

Dr. Bill Wold, Chairman
Dr. Bill Wold, Chairman

The Department has state-of-the-art laboratories located in a research and teaching complex together with other basic science departments in the School of Medicine.

The 9 primary tenure track faculty, 6 research track faculty, and 16 secondary faculty in the Department have strong independent research programs funded by the government, research foundations, and industry. The faculty serve on national peer-review panels and journal editorial boards, are often invited to report on their work at other institutions, and their research is published in highly visible scientific journals. Students in the department receive progressive didactic instruction and extensive cutting-edge research training in virology, immunology, molecular biology, cell biology, cell-cell interactions.


Research in the Department of Molecular Microbiology and Immunology reflects the strength and diversity of its faculty through a unifying focus of the study of host-pathogen interactions, especially in the areas of virology and immunology.

General areas of interest include:
  • viral pathogenesis
  • immunology
  • molecular and cellular biology
  • biodefense
The virology program is one of the strongest in the USA, and it encompasses research on:
  • adenoviruses
  • hepatitis B and C viruses
  • Herpes simplex virus
  • HIV (structure-function of integrase enzyme)
  • poxviruses (including model studies for smallpox)
  • anti-viral drug therapy
  • cancer gene therapy using viral vectors
  • vaccines
The immunology program includes research on:
  • immunotherapy of cancer
  • regulatory T cells in autoimmune disease
  • molecular mechanisms that control regulatory T cells
  • immunotherapy of chronic viral infection
  • osteoimmunology
  • cytokine function
  • vaccine development (discovery and clinical trials)
  • nutrophils and natural killer cells
  • immunotherapeutic approaches to chronic virus infections
  • dendritic cells in autoimmune disease
  • inflammation and gastric cancer
Other research:
  • parasites (T. cruzi)
  • Mycobacterium tuberculosis
  • cell cycle regulation
  • programmed cell death (apoptosis)
  • ultrasensitive detection of nucleic acids and proteins


Daniel Hawiger, M.D.
Newly Enlisted T-Cell ‘Policemen’ Can Slow Down Run-Away Immune System, SLU Scientist Says

Researcher Daniel Hawiger, M.D., Ph.D., hopes that these breakthroughs will open the door to design better treatments for autoimmune diseases.

Read More >>>


Next page: Faculty